Atlas Trials

Radioimmunotherapy With Lu-177 Labeled 6A10 Fab-fragments in Patients With Glioblastoma After Standard Treatment

Clinical trial NCT05533242 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT05533242
Sponsor
University Hospital Muenster
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Glioblastom WHO Grade 4
Start date
2024-01-22
Primary completion
2026-10-01
Enrollment
15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.